rs3218536, XRCC2

N. diseases: 37
Source: ALL
Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
Breast Carcinoma
CUI: C0678222
Disease: Breast Carcinoma
0.090 GeneticVariation BEFREE Our results suggest that the 135G/C polymorphism of the RAD51, Thr241Met polymorphism of XRCC3 and Arg188His polymorphism of XRCC2 can be independent markers of breast cancer risk in Pakistan. 25556451 2014
Breast Carcinoma
CUI: C0678222
Disease: Breast Carcinoma
0.090 GeneticVariation BEFREE No significant association was observed between the XRCC2 Arg188His polymorphism and breast cancer susceptibility (dominant model: OR = 0.94, 95%CI = 0.86-1.04, P = 0.232). 24621646 2014
Breast Carcinoma
CUI: C0678222
Disease: Breast Carcinoma
0.090 GeneticVariation BEFREE In the present study, we showed the association between RAD51 G135C polymorphism and the incidence of breast cancer (p < 0.0001), but found no significant association with XRCC2 Arg188His or XRCC3 Thr241Met polymorphism. 21701125 2011
Breast Carcinoma
CUI: C0678222
Disease: Breast Carcinoma
0.090 GeneticVariation BEFREE However, when the population was stratified according to breast feeding (women that breast fed and women that never breast fed) it is observed, in women that never breast fed, that the heterozygous individuals for the XRCC2 (Ex3+442G>A, R188H, rs3218536) polymorphism have a decreased risk for breast cancer [adjusted OR=0.45; 95% CI=0.22-0.92] (P=0.03). 20004634 2010
Breast Carcinoma
CUI: C0678222
Disease: Breast Carcinoma
0.090 GeneticVariation BEFREE In summary, the present meta-analysis suggests that the XRCC2 Arg188His is not directly associated with breast cancer risk. 20127279 2010
Breast Carcinoma
CUI: C0678222
Disease: Breast Carcinoma
0.090 GeneticVariation BEFREE None of these tagging SNPs was associated with breast cancer risk, with the exception of XRCC2 rs3218536, R188H, which showed some evidence of a protective association for the rare allele [per allele odds ratio, 0.89; 95% confidence intervals (95% CI), 0.80-0.99; P trend = 0.03]. 19064565 2008
Breast Carcinoma
CUI: C0678222
Disease: Breast Carcinoma
0.090 GeneticVariation BEFREE Genotyping was conducted for polymorphisms in four genes involved in repair of radiation-induced DNA damage, the double-strand break repair pathway: X-ray cross-complementing group 3 (XRCC3) codon 241 Thr/Met, Nijmegen breakage syndrome 1 (NBS1) codon 185 Glu/Gln, X-ray cross-complementing group 2 (XRCC2) codon 188 Arg/His, and breast cancer susceptibility gene 2 (BRCH2) codon 372 Asn/His. 16214912 2005
Breast Carcinoma
CUI: C0678222
Disease: Breast Carcinoma
0.090 GeneticVariation BEFREE We observed that the XRCC2 R188H polymorphism modified the association of plasma alpha-carotene level and breast cancer risk (test for ordinal interaction, P=0.03); the significantly decreased risk seen overall for women in the highest quartile of plasma alpha-carotene was only present among 188H non-carriers (the top quartile versus the bottom quartile; multivariate odds ratio, 0.55; 95% confidence interval, 0.40-0.75). 14578164 2004
Breast Carcinoma
CUI: C0678222
Disease: Breast Carcinoma
0.090 GeneticVariation BEFREE Carriage of the rare allele of XRCC2 R1</span>88H was associated with breast cancer overall [odds ratio 1.3; 95% confidence interval (CI)=(1.0, 1.8)] and when younger-onset cases with a positive family history were compared with older controls with no family history [odds ratio 1.9; 95% CI=(1.0, 3.8)]. 12023985 2002